Brighter officially kicks-off commercial phase at GITEX in Dubai.
Brighter is currently participating in GITEX Tech Week in Dubai alongside Ericsson, a Brighter partner since 2015. During the event, Brighter’s CEO Henrik Norström will introduce Actiste – the world’s most cutting-edge and innovative diabetes monitoring and treatment service – and announce that Brighter is now officially ready to deliver Actiste® Diabetes Management as a Service in UAE and the wider GCC region.
The event follows the announcement of the two EC certificates (CE marks) that Actiste® received recently from the European Notified Body TÜV Rheinland.
Brighter is currently registering Actiste with the national authorities in the UAE as part of its commercial roll-out. In line with the company’s market introduction process, Brighter and its partners, conducts User Experience Pilots to fine tune adaption for the local market.
“As communicated in January, our first launch is with the UAE Ministry of Health and Prevention. The UAE is at the forefront of digital health implementation, as part of the Ministry’s strategic plan 2017-2021. Our presence in the UAE will also allow us to build additional reach to more patients in the region,” says Henrik Norström, CEO Brighter.
The total number of people living with diabetes in the UAE is currently 1.2 million according to The International Diabetes Federation (IDF) of which approximately 480.000 are insulin-dependent and could benefit from Brighter’s Actiste service.
“Today we are witnessing an important milestone and we are seeing a good example of how connectivity can transform people’s lives to the better. Our global partnership with Brighter has now reached a stage of real deliveries to the market, utilizing the global connectivity service based on our IoT Accelerator. We are proud to be part of enhancing the HealthCare industry in UAE and improving quality of life for the patients,” says Fadi Pharaon, President of Ericsson Middle East and Africa.
Ericsson IoT Accelerator is a trusted and easy-to-use IoT platform, providing global connectivity and device management.
“By partnering with Ericsson, we are able to offer a truly seamless customer experience. No matter where in the world patients decide to go, their generated health and treatment data will always be securely stored and available to improve treatments,” says Henrik Norström.
For further information, please contact:
Henrik Norström, CEO
Phone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
Rasmus Karlgren, Media & Communications Manager
Phone: +4672 999 38 64
Email: rasmus.karlgren@brighter.se
About Actiste®
Actiste® is the world's first complete IoT-health solution for monitoring and treating insulin-dependent diabetes, bringing together all required functions in a single connected device: blood sampling, blood glucose measurement and insulin injection. The device is based on patented technology for the collection of data on specified bio-markers and volumes of medication injected. Using state-of-the-art eSIM technology, provided by the industry leading ICT company Ericsson, the device has global out-of-the-box connectivity, making it completely independent of other devices to share health and treatment data. Actiste was awarded CE mark in September 2019.
The device is delivered as part of a subscription service; Actiste® Diabetes Management as a Service. The service includes global connectivity, different levels of data sharing, continuous replenishment of everyday supplies and enables individualized coaching to optimize and improve treatments. https://actiste.com/
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/
The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.
